期刊文献+

选择性动脉介入治疗急性重症胰腺炎的疗效分析 被引量:5

Efficacy of selective arterial interventional therapy in severe acute pancreatitis
原文传递
导出
摘要 目的观察选择性动脉介入治疗急性重症胰腺炎(severe acute pancreatitis,SAP)患者的临床疗效。方法103例SAP患者,55例患者接受静脉注药治疗(对照组),48例患者接受选择性动脉介入治疗(介入组),比较接受两种治疗方法的患者在住院期间的临床疗效。结果分析对照组和介入组的临床疗效:两者病死率分别为16.4%和4.17%,(P<0.05);对照组和介入组血清淀粉酶恢复正常时间分别为(7.8±2.9)dvs.(3.5±1.6)d,(P<0.05);对照组和介入组中需外科手术者比率分别为(34.5%vs.16.7%),(P<0.05);介入组住院时间为(24.9±18.3)d,较对照组住院时间明显缩短。结论选择性动脉介入治疗有效地提高抢救成功率,减少患者出现严重并发症,从而降低病死率,缩短住院时间。 Objective To compare the efficacy of selective artery interventional therapy and intravenous therapy in severe acute pancreatitis. Methods Among of 103 patients with severe acute pancreatitis, 55 were treated with intravenous therapy , 48 were treated with selective arterial interventional therapy. The clinical outcomes between two groups were compared. Results Mortality was higher in the intravenous therapy group than in the interventional therapy group (16.4% vs. 4.25 %, P 〈 0. 05). The time for serum amylase to normalize was less in the interventional therapy group than in the intravenous therapy group (3.5 ±1.6) d vs. (7.8 ±2.9) d, ( P 〈 0.05). The operation rate between intravenous therapy group and the interventional therapy group was 35.3% vs. 17 %, ( P 〈 0.05)o The average was less in the interventional therapy group than in intravenous therapy group. Conclusion The selective artery interventional therapy was more effective than intravenous therapy in severe acute pancreatitis. Interventional therapial could reduce the mortality and length of stay of patients with SAP.
出处 《中华急诊医学杂志》 CAS CSCD 2005年第12期993-995,共3页 Chinese Journal of Emergency Medicine
关键词 急性重症胰腺炎 介入治疗 静脉注药 Severe acute pancreatitis Interventional therapy Intravenous therapy
  • 相关文献

参考文献4

二级参考文献14

  • 1裘正军 花天放 等.丹参和大剂量补液对急性坏死性胰腺炎大鼠脂质炎症介质的影响[J].中华肝胆外科杂志,1999,5(2):78-78.
  • 2王田和宪 小钟亚男 砂村真琴 等.重症急性胰腺炎の新的治疗.最新医学,1992,47(9):2168-2174.
  • 3Trudel JL, Wittnich C, Brown RA. Antibiotics bioavailability in acute experimental pancreatitis[ J ]. J Am Coll Surg, 1994,178 (5) :475- 479.
  • 4Nishimaki H, Takigawa M, Sohma K, et al. Progress in interventional radiology (IVR) in emergency medicine[ J]. Nippon Geka Gakkai Zasshi, 1999,100 (7): 435 - 442.
  • 5Kylanpaa A,Back ML, Takala A, et al. Cellular markers of systemic inflammation and immunesuppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol,2001,36(10): 1100.
  • 6Arnalich F, Garcia-Palomero E, Lopez J, et al. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis.Infection And Immunity,2000,68(4):1942-1945.
  • 7Muller JM, Ziegler-Hettbrock HW, Baeuerle PA. Nuclear factor kappaB, a mediator of Lipopolysaccaride effects. Immunobiol,1993,187(3):233-256.
  • 8Rau B, Steinbach G, et al. Clinical value of lipopolysaccharide-binding protein (LBP)determinations in acute pancreatitis. Langenbecks Arch Surg,2003,388(3): 181-188.
  • 9Kitchens RL. Role of sCD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol,2000,74(1):61-82.
  • 10刘续宝,张肇达,严律南,袁朝新,张刚,吴言涛,康德英.急性胰腺炎胰和胰周坏死组织感染的危险因素分析[J].普外基础与临床杂志,1997,4(4):207-209. 被引量:12

共引文献113

同被引文献53

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部